Gilenya Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials

Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation
Conditions:   Interstitial Fibrosis;   Kidney Transplant; Complications;   Kidney Transplant Rejection;   Kidney Transplant Failure and Rejection;   Kidney Transplant Failure;   Kidney Failure, Chronic;   Graft Rejection Interventions:   Drug: Fingolimod;   Drug: Placebo Sponsor:   The Methodist Hospital Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2022 Category: Research Source Type: clinical trials